Fig. 2From: Survival after hypofractionation in glioblastoma: a systematic review and meta-analysisMeta-analysis of controlled trials analysing by design (a) (observational vs. randomized studies) and by median age (b) (<65 years vs ≥65 years) testing hypofractionation on newly diagnosed high-grade glioma or glioblastoma. The size of the symbols is proportional to the number of included patientsBack to article page